Thursday 25 August 2022

New MS Treatment Shows Promise in Trial

photo of medical researcher

The drug ublituximab beat a standard oral medication for MS in reducing patients' relapses and proved better at preventing areas of inflammatory damage in the brain.



from WebMD Health https://ift.tt/HRDxgy1

0 comments:

Post a Comment